2S20 20mg*10vials

SS-31 2S20 20mg x 10 Vials

Product Overview

SS-31 2S20 is an upgraded formulation in the mitochondrial repair and anti-aging peptide series, serving as a fortified intermediate version of the basic 2S10 10mg product. This double-concentration version retains the unique cell-permeable structure, precise mitochondrial targeting, and antioxidant cardiolipin-binding repair mechanism of the SS-31 series, enhancing mitochondrial protection, oxidative stress inhibition, and bioenergy optimization. The 20mg formulation supports deeper mitochondrial structural repair, stronger endogenous reactive oxygen species scavenging saturation, and more thorough respiratory chain functional remodeling. It is designed for moderate mitochondrial damage modeling, high-intensity oxidative stress intervention, neurodegenerative disease and cardiovascular mitochondrial damage research, and peptide complex synergistic deep anti-aging validation, serving as an upgraded preclinical research material for mitochondrial pathophysiology and efficient organ protection mechanism studies.

Core Research Functions

Cardiolipin Binding and Mitochondrial Structure Stabilization: Supports enhanced cardiolipin binding saturation research and mitochondrial cristae structure and membrane potential stabilization studies.

Endogenous ROS Source Inhibition: Supports strengthened endogenous reactive oxygen species (ROS) source inhibition research and deeper persistent oxidative cascade damage blocking studies.

Respiratory Chain Repair and Energy Optimization: Supports enhanced respiratory chain repair research and ATP energy synthesis efficiency improvement studies.

Oxidative Apoptosis and Degenerative Aging Intervention: Supports oxidation-induced apoptosis inhibition and moderate degenerative aging intervention research.

Compared to the milder basal regulator 2S10, 2S20 20mg exhibits faster experimental phenotypic responses, stronger oxidative stress threshold tolerance, and more durable mitochondrial protective efficacy. It supports research on moderate mitochondrial pathological damage caused by persistent oxidation, including cristae breakage, membrane depolarization, and weakened energy metabolism. It supports research on intracellular accumulated free radical elimination, cellular energy deficiency and fatigue phenotype improvement, and secondary inflammatory damage reduction caused by mitochondrial dysfunction. It also supports neuroprotective and cardiovascular mitochondrial protective effect research, and multi-organ physiological function stabilization under mild oxidative stress conditions. The 20mg balanced formulation supports medium-to-high dose gradient threshold screening, moderate mitochondrial dysfunction mechanism modeling, and complex peptide-synergistic mitochondrial repair research, providing high-precision, reproducible data for mitochondrial antioxidant and organ anti-aging pharmacology research.

Key Advantages

Enhanced Mitochondrial Targeted Repair: Based on the standard 10mg formulation, the effective concentration is doubled, supporting improved cardiolipin binding saturation and deeper mitochondrial structural repair research, exceeding the limited efficacy range of basic low-dose SS-31 variants.

Saturation Source-Level Oxidative Stress Inhibition: Possesses stronger endogenous ROS scavenging and oxidative cascade blocking capabilities, supporting moderate persistent oxidative damage model intervention research that exceeds low-dose regimen repair ranges, achieving saturated mitochondrial antioxidant protection.

Enhanced Bioenergy and Multi-Organ Protection: Further optimizes the mitochondrial respiratory chain, supporting ATP energy synthesis efficiency enhancement, neuroprotective effect research, and cardiovascular mitochondrial protective function studies under oxidative stress conditions.

Mitochondrial Structural and Functional Support: Supports mitochondrial cristae structure stabilization, membrane potential balance maintenance, and mitochondrial bioenergy repair efficiency enhancement research under moderate damage conditions.

High-Standard Aseptic Packaging: 10-vial integrated dust-free aseptic packaging. Each batch undergoes rigorous full-item HPLC purity testing and is accompanied by a complete Certificate of Analysis (COA). With long-term stable activity retention, it is suitable for advanced laboratory mitochondrial mechanism research, high-standard preclinical projects, and customized bulk procurement.

Specifications and Quality Control

Format: Lyophilized powder, 20mg per vial. Packaging: 10 vials per pack, dust-free aseptic integrated container. Purity Testing: Full HPLC purity verification with complete Certificate of Analysis (COA).